Abstract
After environmental contamination, U accumulates in the kidneys and in bones, where it causes visible damage. Recent in vitro data prove that the occurrence of citrate increases U bioavailability without changing its speciation. Two hypotheses can explain the role of citrate: it either modifies the U intracellular metabolization pathway, or it acts on the transport of U through cell membrane. To understand which mechanisms lead to increased bioavailability, we studied the speciation of U after accumulation in NRK-52E kidney cells. U speciation was first identified in various exposure media, containing citrate or not, in which U was supplied as U carbonate. The influence of serum proteins was analyzed in order to detect the formation of macromolecular complexes of U. Transmission electron microscopy (TEM) was employed to follow the evolution of the U species distribution among precipitated and soluble forms. Finally, extended X-ray absorption fine structure spectroscopy (EXAFS) enabled the precipitates observed to be identified as U-phosphate. It also demonstrated that the intracellular soluble form of U is U carbonate. These results suggest that citrate does not change U metabolization but rather plays a role in the intracellular accumulation pathway. U speciation inside cells was directly and clearly identified for the first time. These results elucidate the role of U speciation in terms of its bioavailability and consequent health effects.
Similar content being viewed by others
References
Miller AD (ed) (2006) Depleted uranium. Properties, uses, and health consequences. CRC Press, Boca Raton, FL
Van Horn JD, Huang H (2006) Coord Chem Rev 250:765–775. doi:10.1016/j.ccr.2005.09.010
Vidaud C, Dedieu A, Basset C, Plantevin S, Dany I, Pible O, Quemeneur E (2005) Chem Res Toxicol 18:946–953. doi:10.1021/tx050038vS0893-228x(05)00038-X
Sutton M, Burastero SR (2004) Chem Res Toxicol 17:1468–1480. doi:10.1021/tx049878kS0893-228x(04)09878-9
Leggett RW (1989) Health Phys 57:365–383
Galle P (1997) Uranium. In: Galle P, Paulin R (eds) Toxique Nucléaires. Masson, Paris, pp 185–205
Mirto H, Henge-Napoli MH, Gibert R, Ansoborlo E, Fournier M, Cambar J (1999) Toxicol Lett 104:249–256. doi:10.1016/S0378-4274(98)00371-3
Carrière M, Avoscan L, Collins R, Carrot F, Khodja H, Ansoborlo E, Gouget B (2004) Chem Res Toxicol 17:446–452. doi:10.1021/tx034224hS0893-228x(03)04224-3
Carrière M, Gouget B, Gallien JP, Avoscan L, Gobin R, Verbavatz JM, Khodja H (2005) Nucl Instrum Methods B 231:268–273. doi:10.1016/j.nimb.2005.01.069
Wright SH, Dantzler WH (2004) Physiol Rev 84:987–1049. doi:10.1152/physrev.00040.2003
Templeton DM, Ariese F, Cornelis R, Danielsson LG, Muntau H, Van Leeuwen HP, Lobinski R (2000) Pure Appl Chem 72(8):1453–1470
Carrière M, Thiebault C, Milgram S, Avoscan L, Proux O, Gouget B (2006) Chem Res Toxicol 19:1637–1642. doi:10.1021/tx060206zS0893-228x(06)00206-2
Toutain H, Morin JP (1992) Ren Fail 14:371–383
Phelps PC, Best CJ, Berezesky IK, Merriman RL, Tanzer LR, Boder GB, Trump BF (1995) Cancer Lett 97:7–15
Strum JM, Wicken J, Stanbury JR, Karnovski MJ (1971) J Cell Biol 51:162–175
Proux O, Biquard X, Lahera E, Menthonnex JJ, Prat A, Ulrich O, Soldo Y, Trévisson P, Kapoujvan G, Perroux G, Taunier P, Grand D, Jeantet P, Deleglise M, Roux JP, Hazemann JL (2005) Phys Scr 115:970–973
Proux O, Nassif V, Prat A, Ulrich O, Lahera E, Biquard X, Menthonnex JJ, Hazemann JL (2006) J Synchrotron Radiat 13:59–68. doi:10.1107/S0909049505037441
Ravel B, Newville M (2005) J Synchrotron Radiat 12:537–541. doi:10.1107/S0909049505012719
Allen PG, Bucher JJ, Clark DL, Edelstein NM, Ekberg SA, Gohdes JW, Hudson EA, Kaltsoyannis N, Lukens WW, Neu MP, Palmer PD, Reich T, Shuh DK, Tait CD, Zwick BD (1995) Inorg Chem 34:4797–4807. doi:10.1021/ic00123a013
Bailey EH, Mosselmans JFW, Schofield PF (2005) Chem Geol 216:1–16. doi:10.1016/j.chemgeo.2004.10.011
Clark DL, Hobart DE, Neu MP (1995) Chem Rev 95:25–48. doi:10.1021/cr00033a002
Müller D, Houpert P, Cambar J, Henge-Napoli MH (2006) Toxicol Appl Pharmacol 214:166–177. doi:10.1016/j.taap.2005.12.016
Carrière M, Khodja H, Avoscan L, Carrot F, Gouget B (2005) Radiochim Acta 93:691–697
Acknowledgments
This work was partly supported by the Environmental and Nuclear Toxicology program. We thank J. M. Verbavatz for TEM observations, and J. L. Hazemann for helpful discussions during the EXAFS experiments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carrière, M., Proux, O., Milgram, S. et al. Transmission electron microscopic and X-ray absorption fine structure spectroscopic investigation of U repartition and speciation after accumulation in renal cells. J Biol Inorg Chem 13, 655–662 (2008). https://doi.org/10.1007/s00775-008-0350-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-008-0350-2